Yahoo
NYSE - Delayed Quote USD

Oscar Health, Inc. (OSCR)

14.64 +1.67 (+12.88%)
At close: April 8 at 4:00:02 PM EDT
14.43 -0.20 (-1.37%)
Pre-Market: 4:47:17 AM EDT
Trade OSCR on Coinbase
Chart Range Bar
Loading chart for OSCR
  • Previous Close 12.97
  • Open 14.34
  • Bid 14.44 x 290000
  • Ask --
  • Day's Range 14.06 - 14.98
  • 52 Week Range 10.69 - 23.80
  • Volume 15,079,458
  • Avg. Volume 7,855,313
  • Market Cap (intraday) 4.359B
  • Beta (5Y Monthly) 1.93
  • PE Ratio (TTM) --
  • EPS (TTM) -1.69
  • Earnings Date May 6, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 15.40

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

www.hioscar.com

2,305

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Performance Overview: OSCR

Trailing total returns as of 4/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

OSCR
1.88%
S&P 500 (^GSPC)
0.92%

1-Year Return

OSCR
24.91%
S&P 500 (^GSPC)
36.13%

3-Year Return

OSCR
124.54%
S&P 500 (^GSPC)
65.23%

5-Year Return

OSCR
39.75%
S&P 500 (^GSPC)
65.55%

Earnings Trends: OSCR

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 2.81B
Earnings -352.61M

Q1

FY25

Q2

FY25

Q3

FY25

Q4

FY25

0
1B
2B
3B

Analyst Insights: OSCR

View More

Analyst Price Targets

10.00 Low
15.40 Average
14.64 Current
23.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 1/9/2026
Analyst UBS
Rating Action Upgrade
Rating Neutral
Price Action Raises
Price Target 12 -> 17

Statistics: OSCR

View More

Valuation Measures

Annual
As of 4/8/2026
  • Market Cap

    4.36B

  • Enterprise Value

    2.01B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.33

  • Price/Book (mrq)

    4.46

  • Enterprise Value/Revenue

    0.17

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.79%

  • Return on Assets (ttm)

    -4.44%

  • Return on Equity (ttm)

    -44.35%

  • Revenue (ttm)

    11.7B

  • Net Income Avi to Common (ttm)

    -443.15M

  • Diluted EPS (ttm)

    -1.69

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.99B

  • Total Debt/Equity (mrq)

    50.86%

  • Levered Free Cash Flow (ttm)

    698M

Compare To: OSCR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: OSCR

Fair Value

14.64 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: